48 results on '"Yu, Catherine"'
Search Results
2. Supplementary Figure S1 from Characteristics of Cancer Epidemiology Studies That Employ Metabolomics: A Scoping Review
3. Supplementary Figure S2 from Characteristics of Cancer Epidemiology Studies That Employ Metabolomics: A Scoping Review
4. Supplementary Figure S1 from Characteristics of Cancer Epidemiology Studies That Employ Metabolomics: A Scoping Review
5. Supplementary Table S2 from Characteristics of Cancer Epidemiology Studies That Employ Metabolomics: A Scoping Review
6. Figure 1 from Characteristics of Cancer Epidemiology Studies That Employ Metabolomics: A Scoping Review
7. Supplementary Table S2 from Characteristics of Cancer Epidemiology Studies That Employ Metabolomics: A Scoping Review
8. Figure 4 from Characteristics of Cancer Epidemiology Studies That Employ Metabolomics: A Scoping Review
9. Supplementary Table S1 from Characteristics of Cancer Epidemiology Studies That Employ Metabolomics: A Scoping Review
10. Supplementary Figure S4 from Characteristics of Cancer Epidemiology Studies That Employ Metabolomics: A Scoping Review
11. Supplementary Figure S3 from Characteristics of Cancer Epidemiology Studies That Employ Metabolomics: A Scoping Review
12. Data from Characteristics of Cancer Epidemiology Studies That Employ Metabolomics: A Scoping Review
13. Figure 3 from Characteristics of Cancer Epidemiology Studies That Employ Metabolomics: A Scoping Review
14. Figure 3 from Characteristics of Cancer Epidemiology Studies That Employ Metabolomics: A Scoping Review
15. Figure 2 from Characteristics of Cancer Epidemiology Studies That Employ Metabolomics: A Scoping Review
16. Data from Characteristics of Cancer Epidemiology Studies That Employ Metabolomics: A Scoping Review
17. Supplementary Figure S5 from Characteristics of Cancer Epidemiology Studies That Employ Metabolomics: A Scoping Review
18. Table 1 from Characteristics of Cancer Epidemiology Studies That Employ Metabolomics: A Scoping Review
19. Supplementary Figure S5 from Characteristics of Cancer Epidemiology Studies That Employ Metabolomics: A Scoping Review
20. Supplementary Figure S6 from Characteristics of Cancer Epidemiology Studies That Employ Metabolomics: A Scoping Review
21. Supplementary Figure S3 from Characteristics of Cancer Epidemiology Studies That Employ Metabolomics: A Scoping Review
22. Figure 4 from Characteristics of Cancer Epidemiology Studies That Employ Metabolomics: A Scoping Review
23. Table 1 from Characteristics of Cancer Epidemiology Studies That Employ Metabolomics: A Scoping Review
24. Supplementary Figure S2 from Characteristics of Cancer Epidemiology Studies That Employ Metabolomics: A Scoping Review
25. Supplementary Table S1 from Characteristics of Cancer Epidemiology Studies That Employ Metabolomics: A Scoping Review
26. Supplementary Figure S4 from Characteristics of Cancer Epidemiology Studies That Employ Metabolomics: A Scoping Review
27. Supplementary Figure S6 from Characteristics of Cancer Epidemiology Studies That Employ Metabolomics: A Scoping Review
28. Figure 2 from Characteristics of Cancer Epidemiology Studies That Employ Metabolomics: A Scoping Review
29. Supplementary Figure S3 from Characteristics of Cancer Epidemiology Studies That Employ Metabolomics: A Scoping Review
30. Characteristics of Cancer Epidemiology Studies That Employ Metabolomics: A Scoping Review
31. Supplementary Table S2 from Characteristics of Cancer Epidemiology Studies That Employ Metabolomics: A Scoping Review
32. Supplementary Figure S3 from Characteristics of Cancer Epidemiology Studies That Employ Metabolomics: A Scoping Review
33. Supplementary Figure S1 from Characteristics of Cancer Epidemiology Studies That Employ Metabolomics: A Scoping Review
34. Supplementary Table S2 from Characteristics of Cancer Epidemiology Studies That Employ Metabolomics: A Scoping Review
35. Supplementary Figure S2 from Characteristics of Cancer Epidemiology Studies That Employ Metabolomics: A Scoping Review
36. Supplementary Figure S4 from Characteristics of Cancer Epidemiology Studies That Employ Metabolomics: A Scoping Review
37. Supplementary Figure S6 from Characteristics of Cancer Epidemiology Studies That Employ Metabolomics: A Scoping Review
38. Supplementary Figure S5 from Characteristics of Cancer Epidemiology Studies That Employ Metabolomics: A Scoping Review
39. Supplementary Figure S2 from Characteristics of Cancer Epidemiology Studies That Employ Metabolomics: A Scoping Review
40. Supplementary Figure S1 from Characteristics of Cancer Epidemiology Studies That Employ Metabolomics: A Scoping Review
41. Supplementary Figure S6 from Characteristics of Cancer Epidemiology Studies That Employ Metabolomics: A Scoping Review
42. Supplementary Figure S5 from Characteristics of Cancer Epidemiology Studies That Employ Metabolomics: A Scoping Review
43. Supplementary Table S1 from Characteristics of Cancer Epidemiology Studies That Employ Metabolomics: A Scoping Review
44. Supplementary Table S1 from Characteristics of Cancer Epidemiology Studies That Employ Metabolomics: A Scoping Review
45. Supplementary Figure S4 from Characteristics of Cancer Epidemiology Studies That Employ Metabolomics: A Scoping Review
46. Data from Characteristics of Cancer Epidemiology Studies That Employ Metabolomics: A Scoping Review
47. Cancer Epidemiology in Hispanic Populations: An Analysis of Funded Observational Research at the National Cancer Institute
48. Abstract 4173: IKBKE/IKKα is a prognostic marker and is required for KRAS-driven tumorigenecity in non-small cell lung cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.